CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 60 enrolled
Drug / intervention
Biliary stentingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00391183
NCT00391183Phase 3Completed
CompareCT.gov

Effect of Palliative Biliary Stenting Versus Conservative Treatment on the Quality of Life (QOL) of Patients With Unresectable Carcinoma of the Gallbladder With Hiliar Block: A Randomised Controlled Trial

All India Institute of Medical Sciences·interventional·Posted Oct 23, 2006·Updated Jul 11, 2013

In Brief

A Phase 3 clinical trial evaluating Biliary stenting for Gallbladder Cancer. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The purpose of the study is to determine whether palliative biliary stenting improves the quality of life, of gallblader cancer patients, who present with hilar block and obstructive jaundice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGallbladder Cancer
CountriesIndia
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 23, 2006
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 19.7 years ago

Interventions

Biliary stentingprocedure

ERCP and stenting